Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Other Accumulated Expenses (2020 - 2025)

Healthcare Triangle's Other Accumulated Expenses history spans 6 years, with the latest figure at $268000.0 for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 80.66% to $268000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $268000.0, a 80.66% decrease, with the full-year FY2025 number at $268000.0, down 80.66% from a year prior.
  • Other Accumulated Expenses hit $268000.0 in Q4 2025 for Healthcare Triangle, down from $1.1 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for HCTI hit a ceiling of $3.0 million in Q1 2023 and a floor of $268000.0 in Q4 2025.
  • Historically, Other Accumulated Expenses has averaged $1.3 million across 5 years, with a median of $1.1 million in 2024.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 202.6% in 2023 and later plummeted 80.66% in 2025.
  • Tracing HCTI's Other Accumulated Expenses over 5 years: stood at $869000.0 in 2021, then skyrocketed by 179.75% to $2.4 million in 2022, then dropped by 21.39% to $1.9 million in 2023, then dropped by 27.47% to $1.4 million in 2024, then plummeted by 80.66% to $268000.0 in 2025.
  • Business Quant data shows Other Accumulated Expenses for HCTI at $268000.0 in Q4 2025, $1.1 million in Q3 2025, and $670000.0 in Q2 2025.